Vinpai SAS
ALVIN.PA
Euronext Paris3.60
EUR
- -
- -
Vinpai SAS
ALVIN.PA
(Euronext Paris)
Recent
price
3.60
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Vinpai SAS (ALVIN.PA) designs, manufactures and markets functional ingredients based on algae, plants, minerals and fibers as natural alternatives to chemical additives for the food, cosmetics, nutraceuticals and medical devices industries; its core offerings include plant-based flavors, premixes for analogue cheeses, dairy products, dressing sauces, French fries, cakes and sweetness products; technical and algae-origin solutions such as salt reduction, filling, meat applications and algal texturing for food; algaromatherapy, algatherapy ingredients, ocean sulfated polysaccharides, essential trace elements, amino acids, biomic fibers and unsaturated fatty acids for food supplementation; algae-mineral peel-off masks, actives and ingredients solutions for cosmetics; and algae-origin medical devices including algin patches, molding powders, aesthetic and dental hygiene products. Founded in 2011 and headquartered in Saint-Dolay, France, with production sites in Saint-Dolay and near Saint-Nazaire, the company operates two facilities, employs around 43-47 people and serves customers in over 36 countries with more than 70% of its €9.2 million 2024 revenue generated from exports, primarily in the food sector (83% of sales). Recent developments include a May 2024 strategic partnership with Enhance Gourmet Foods in India to supply plant-based ingredients for vegan cheeses and expand in Asia, the launch of Vin'Curd+ in Q2 2024 for cheese coagulation productivity and ULTRATEX CARE for cold-process cosmetic emulsions, a February 2025 memorandum of understanding with Camlin Fine Sciences Ltd. for a majority stake acquisition supported by €3.3 million in convertible bonds to repay debt and bolster cash, and confirmation of 2026 targets for €16 million revenue and over 10% EBITDA margin amid ongoing industrial scaling and international growth.